ArticleAmerican journal of translational research2022

Effects of PD-1 inhibitor combined with anti-angiogenic drugs on efficacy and immune function of non-small cell lung cancer.

Yuan Zhang et al.PubMed ↗Full text ↗

No numbers read from the abstract.